Finance
Markets
No recent trading data. The last price we hold for MRK is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

MRK

stock Healthcare Drug Manufacturers - General
Merck & Co.
$114.80 -0.85 (-0.73%) Delayed · quoted 47d ago
Healthy 81% Climbing

What the indicators say

Mixed 3 of 5 trend signals bullish
Momentum · RSI 14 Neutral
48
0oversold 30overbought 70100

RSI 48 — momentum is balanced between buyers and sellers.

EMA 21 $115.80
Below
Near-term trend is down
SMA 50 $116.07
Below
Medium-term trend is down
SMA 200 $103.57
Above
Long-term trend is up
50 / 200-day
Golden cross
50-day above the 200-day — bullish
Supertrend $112.17
Uptrend
Price is holding above the Supertrend band — bullish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $114.73 High $117.33
Open
$114.80
-0.73%
Close
$114.80
-0.73%
52-week range where the price sits across its year
52w low $75.44 52w high $125.14
Current
$114.80
Prev close
$115.65
Volume 0.64× the 3-month average
0 avg 2× avg
Today
6.01M
3-mo avg
9.43M

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 3082 days ago
Next expected
Aug 4in 14 days

Recent earnings dates

  • Apr 30 82 days ago
  • Feb 3 168 days ago
  • Oct 30, 2025 264 days ago
  • Jul 29, 2025 357 days ago

Past earnings dates come from MRK’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 53d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), MRK’s fundamentals read as strong overall.

P/E ratio Fair
32.3x

At 32.3x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Strong
2.86%

A 2.9% yield is a healthy, generally sustainable level of cash income.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
28.1%

A 28.1% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Strong
34.7%

A 34.7% return on equity is strong; the company compounds owners' capital well.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Strong
13.3%

A 13.3% return on assets is strong; the company squeezes good profit from its assets.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
—

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.54

At 1.54, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+1.3%

Revenue grew 1.3% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Fair
+6.6%

Net income grew 6.6% from the prior year: steady profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 53d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $48.7B$59.3B$60.1B$64.2B$65.0B
Net income $13.0B$14.5B$365.0M$17.1B$18.3B
Diluted EPS $5.14$5.71$0.14$6.74$7.28
Dividend / share $2.64$2.80$2.96$3.12$3.28
Total assets $105.7B$109.2B$106.7B$117.1B$136.9B
Total liabilities —————
Shareholder equity $38.3B$46.1B$37.6B$46.3B$52.6B

Leadershipsynced from SEC 59d ago

  • Davis Robert M Chairman, CEO & President · Director
  • Litchfield Caroline EVP & CFO
  • Chattopadhyay Sanat Exe V-P & Pres. MMD
  • Deluca Richard R. EVP&Pres, Merck Animal Heallth
  • Foard Brian EVP, Specialty, Pharma, & ID
  • Guindo Chirfi EVP, Access, Policy & Comms
  • Larson Betty D EVP, Chief HR Officer
  • Li Dean Y Executive VP & President, MRL
  • Maraldo David R. EVP & Pres. MMD
  • Oosthuizen Johannes Jacobus EVP, Oncology & Int?l
  • Smart Dalton E. Iii SVP Fin. - Global Controller
  • Williams David Michael EVP,Chief Info&Digital Officer
  • Zachary Jennifer EVP, General Counsel
  • Coe Mary Ellen Director
  • Glocer Thomas H Director
  • Seidman Christine E Director

Officers and board are drawn from MRK’s recent SEC ownership filings (Forms 3, 4 and 5).

Recent leadership changes

Notable recent eventspast year

  • May 22 +5.6% one-day move
  • Nov 25, 2025 +5.2% one-day move
  • Oct 1, 2025 +7.4% one-day move
  • Sep 30, 2025 +6.8% one-day move

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Strong
2025 total
$3.28
2026 so far
$0.851 payment
2026 projected
$3.40+3.7% vs 2025

Projection scales MRK’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • Mar 16 $0.85
  • Dec 15, 2025 $0.85
  • Sep 15, 2025 $0.81
  • Jun 16, 2025 $0.81
  • Mar 17, 2025 $0.81
  • Dec 16, 2024 $0.81
  • Sep 16, 2024 $0.77
  • Jun 17, 2024 $0.77
  • Mar 14, 2024 $0.77
  • Dec 14, 2023 $0.77
  • Sep 14, 2023 $0.73
  • Jun 14, 2023 $0.73
  • Mar 14, 2023 $0.73
  • Dec 14, 2022 $0.73
  • Sep 14, 2022 $0.69
  • Jun 14, 2022 $0.69
  • Mar 14, 2022 $0.69
  • Dec 14, 2021 $0.69
  • Sep 14, 2021 $0.65
  • Jun 14, 2021 $0.65

Recent SEC filingssynced from SEC 53d ago

© 2026 Isaac Bythewood · Some rights reserved